Christian Weber is Professor at the Department of Biochemistry CARIM, and the Chair in Vascular Medicine and the Director of the Institute for Cardiovascular Prevention at Ludwig‐Maximilians‐University (LMU) Munich, Germany, since 2010. After graduating and completing his training in internal medicine at LMU and Harvard Medical School, Boston, he was board‐certified in clinical cardiology and appointed as a Chair in Molecular Cardiology at RWTH Aachen University. His group has a strong interest in the molecular interactions and pathophysiological functions of chemokines and immune cell subsets, as well as the role of microRNAs and their targets in vascular disease, namely atherosclerosis, while his clinical interests are focused on developing novel biomarkers and peptide-based biopharmaceuticals. He is the Spokesman of the DFG Collaborative Research Centre SFB1123 and coordinates the partner site Munich Heart Alliance in the German Centre for Cardiovascular Research (DZHK). Among many other awards, he is a VICI laureate double ERC Advanced Investigator Grant recipient with more than 470 publications and an h‐index of 84. He serves as the Editor‐in‐Chief of Thrombosis & Haemostasis, Senior Assoicate Editor of Arteriosclerosis, Thrombosis & Vascular Biology and is the co‐founder of Carolus Therapeutics Inc.

Chemokine interactome